MX2015016387A - Degradable haemostat composition. - Google Patents

Degradable haemostat composition.

Info

Publication number
MX2015016387A
MX2015016387A MX2015016387A MX2015016387A MX2015016387A MX 2015016387 A MX2015016387 A MX 2015016387A MX 2015016387 A MX2015016387 A MX 2015016387A MX 2015016387 A MX2015016387 A MX 2015016387A MX 2015016387 A MX2015016387 A MX 2015016387A
Authority
MX
Mexico
Prior art keywords
haemostat composition
degradable
degradable haemostat
composition
physicians
Prior art date
Application number
MX2015016387A
Other languages
Spanish (es)
Inventor
Hoggarth Andrew
Gladman June
Hardy Craig
Original Assignee
Medtrade Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Ltd filed Critical Medtrade Products Ltd
Publication of MX2015016387A publication Critical patent/MX2015016387A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/64—Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0042—Materials resorbable by the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dispersion Chemistry (AREA)
  • Composite Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

The present invention relates to a haemostat composition that is able to safely gradually and fully degrade in a human or animal body within about 30 days and so can be utilised by physicians to stem a flow of blood and promote healing both after as well as during surgical procedures.
MX2015016387A 2013-05-30 2014-05-28 Degradable haemostat composition. MX2015016387A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1309674.8A GB2514592A (en) 2013-05-30 2013-05-30 Degradable haemostat composition
PCT/GB2014/051624 WO2014191738A1 (en) 2013-05-30 2014-05-28 Degradable haemostat composition

Publications (1)

Publication Number Publication Date
MX2015016387A true MX2015016387A (en) 2016-10-14

Family

ID=48805490

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016387A MX2015016387A (en) 2013-05-30 2014-05-28 Degradable haemostat composition.

Country Status (16)

Country Link
US (3) US10933160B2 (en)
EP (1) EP3003411B1 (en)
JP (1) JP6608808B2 (en)
KR (1) KR102324247B1 (en)
CN (2) CN114949334A (en)
AU (1) AU2014272868C1 (en)
BR (1) BR112015029956B1 (en)
CA (1) CA2913658C (en)
DK (1) DK3003411T3 (en)
ES (1) ES2897623T3 (en)
GB (1) GB2514592A (en)
MX (1) MX2015016387A (en)
PL (1) PL3003411T4 (en)
PT (1) PT3003411T (en)
RU (1) RU2682717C2 (en)
WO (1) WO2014191738A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178829A1 (en) * 2015-05-06 2016-11-10 Gyrus Acmi, Inc. (D.B.A. Olympus Surgical Technologies America) Carboxymethyl chitosan sponge formulation
RU2635465C1 (en) * 2016-08-10 2017-11-13 Александр Евгеньевич Федотов Hemostatic material, hemostatic means and material based thereon
TR201714879A2 (en) * 2017-10-03 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi HEMOSTATIC COMPOSITIONS
CN111787892A (en) * 2017-12-29 2020-10-16 金珂生物医疗公司 Tissue adherent chitosan materials resistant to dissolution
WO2019133899A1 (en) * 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Chitosan dressing for control of bleeding in transurethral prostatectomy
WO2019133894A1 (en) 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Delivery systems for control of gastrointestinal bleeding
WO2019133898A1 (en) * 2017-12-29 2019-07-04 Tricol Biomedical, Inc. Chitosan dressing for control of gastrointestinal bleeding
US11660236B2 (en) 2017-12-29 2023-05-30 Tricol Biomedical, Inc. Delivery systems for control of bleeding in transurethral prostatectomy
AU2019207880B2 (en) * 2018-01-12 2024-04-11 Boston Scientific Scimed, Inc. Powder for achieving hemostasis
CN109432481A (en) * 2018-12-06 2019-03-08 广州润虹医药科技股份有限公司 A kind of polyurethane dressing of hemostatic and antibacterial and preparation method thereof
CN115087469A (en) 2019-12-26 2022-09-20 工匠实验室株式会社 Method for producing local hemostatic material and local hemostatic material
CN111714689B (en) * 2020-07-09 2022-04-22 石家庄亿生堂医用品有限公司 Chitosan styptic powder and preparation method thereof
CN114748676B (en) * 2022-04-08 2022-11-18 四川大学 Chitosan-based efficient hemostatic with Janus structure and preparation method and application thereof

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394373A (en) * 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
JPS624232A (en) * 1985-07-01 1987-01-10 Unitika Ltd Hemostatic agent
US5064653A (en) * 1988-03-29 1991-11-12 Ferris Mfg. Co. Hydrophilic foam compositions
US5169535A (en) * 1989-09-22 1992-12-08 Kurita Water Industries Ltd. Method of removing endotoxin
JP3569927B2 (en) * 1993-03-15 2004-09-29 栗田工業株式会社 Endotoxin removal method
US5578661A (en) * 1994-03-31 1996-11-26 Nepera, Inc. Gel forming system for use as wound dressings
EP1401352B1 (en) * 2001-06-14 2012-03-21 Kenton W. Gregory Method for producing a chitosan wound dressing
EP1469865A4 (en) * 2001-12-31 2010-04-14 Crosslink D Inc Hemostatic compositions and methods for controlling bleeding
US8269058B2 (en) * 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
JP2005145873A (en) * 2003-11-14 2005-06-09 Kyoko Koto Method for preparing peptidic or proteinic medicament release control agent and the resulting release control agent
ES2384519T3 (en) * 2004-02-23 2012-07-06 Loma Linda University Medical Center Hemostatic agent for topical and internal use
AU2005221699A1 (en) * 2004-03-11 2005-09-22 Medtrade Products Limited Compositions of alpha and beta chitosan and methods of preparing them
CN1833732A (en) 2005-03-17 2006-09-20 李毅彬 Making method of and use of antibiotic surgical dressing
US9078949B2 (en) 2005-06-14 2015-07-14 Genis Hf. Compositions of partially deacetylated chitin derivatives
AU2006268143A1 (en) * 2005-07-13 2007-01-18 Hemcon, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan
WO2007040557A1 (en) * 2005-09-21 2007-04-12 Surmodics, Inc. Coatings and articles including natural biodegradable polysaccharides
GB0526503D0 (en) * 2005-12-29 2006-02-08 Medtrade Products Ltd Hemostatic material
US20080248508A1 (en) 2006-08-17 2008-10-09 Shenda Baker Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials
WO2008063503A2 (en) * 2006-11-13 2008-05-29 Hawaii Chitopure, Inc. Methods of making a chitosan product having an ultra-low endotoxin concentration and the ultra-low endotoxin chitosan product derived therefrom and method of accurately determining inflammatory and anti-inflammatory cellular response to such materials.
US8932560B2 (en) * 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
CN101081308A (en) * 2007-05-14 2007-12-05 罗晓浔 Chitose haemostatic
CN101053669B (en) * 2007-05-22 2010-05-26 中国海洋大学 Water soluble chitosan-based hemostatic wound-healing marine sponge and its preparation method and application
WO2009011856A1 (en) * 2007-07-16 2009-01-22 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan
CZ2007716A3 (en) * 2007-10-15 2009-04-29 Elmarco S. R. O. Process for producing nanifibers
KR101545506B1 (en) * 2007-10-30 2015-08-19 비스코겔 에이비 Chitosan composition
GB2461019B (en) 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
GB2463523B (en) * 2008-09-17 2013-05-01 Medtrade Products Ltd Wound care device
US20100100123A1 (en) * 2008-10-17 2010-04-22 Confluent Surgical, Inc. Hemostatic implant
EP2408435B1 (en) 2009-03-16 2019-04-24 University Of Memphis Research Foundation Compositions and methods for delivering an agent to a wound
CN101601643A (en) * 2009-06-30 2009-12-16 复旦大学附属中山医院 A kind of skeleton hemostasis gel
CA2812635A1 (en) * 2009-07-14 2011-01-20 Trustees Of Tufts College Electrospun silk material systems for wound healing
RU2468129C2 (en) * 2010-12-30 2012-11-27 Государственное образовательное учреждение высшего профессионального образования "Саратовский государственный университет им. Н.Г. Чернышевского" Biopolymeric fibre, composition of forming solution for its obtaining, method of forming solution preparation, linen of biomedical purpose, biological bandage and method of wound treatment
GB201104175D0 (en) 2011-03-11 2011-04-27 Medtrade Products Ltd Haemostatic material
GB201205174D0 (en) * 2012-03-23 2012-05-09 Medtrade Products Ltd Process for producing low endotoxin chitosan
CN103100107B (en) * 2013-01-25 2014-08-20 安吉县阳光医药用品有限责任公司 Method for preparing medical chitin biological dressing

Also Published As

Publication number Publication date
DK3003411T3 (en) 2021-09-20
US20170258959A1 (en) 2017-09-14
KR20160033661A (en) 2016-03-28
US10933160B2 (en) 2021-03-02
CA2913658C (en) 2022-08-02
PL3003411T3 (en) 2022-01-24
RU2015155733A (en) 2017-07-06
RU2682717C2 (en) 2019-03-21
KR102324247B1 (en) 2021-11-08
PL3003411T4 (en) 2022-01-24
PT3003411T (en) 2021-09-22
GB2514592A (en) 2014-12-03
EP3003411B1 (en) 2021-06-16
WO2014191738A8 (en) 2015-12-23
US20170258958A1 (en) 2017-09-14
CN105431176A (en) 2016-03-23
EP3003411A1 (en) 2016-04-13
AU2014272868A1 (en) 2016-01-21
GB201309674D0 (en) 2013-07-17
AU2014272868C1 (en) 2018-09-06
BR112015029956B1 (en) 2020-11-03
WO2014191738A1 (en) 2014-12-04
JP2016522208A (en) 2016-07-28
ES2897623T3 (en) 2022-03-02
US20160106882A1 (en) 2016-04-21
BR112015029956A2 (en) 2017-07-25
CA2913658A1 (en) 2014-12-04
JP6608808B2 (en) 2019-11-20
CN114949334A (en) 2022-08-30
AU2014272868B2 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
MX2015016387A (en) Degradable haemostat composition.
MX2015016381A (en) Degradable haemostat composition.
IN2015DN01883A (en)
PH12013500892A1 (en) Composition for use in the prevention and/or treatment of skin conditions and skin diseases
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
PH12015502302B1 (en) Treatment of allergic rhinitis using a combination of mometasone and olopatadine
BR112013022961A2 (en) absorbent article including a buffer composition
GEP20166449B (en) Treatment of pain associated with dislocation of basal endometrium
EA201490509A1 (en) Biocompatible catheter
CA2899775C (en) Compositions and methods for pain relief without numbness
BR112015013374A2 (en) hemostatic glove device and method for using it
GB201710822D0 (en) Methods and medical uses relating to the treatment of hypoglycaemia
WO2011091154A3 (en) Use of human erythrocytes for prevention and treatment of cancer dissemination and growth
PH12014501044B1 (en) Methods for improved wound closure employing olivamine and human umbilical vien endothelial cells
UA56157U (en) method for rendering aid to patients with post-traumatic otoliquorea acute period of craniocerebral traumas at fractures of temporal bone
WO2010111108A3 (en) Compositions and methods for the treatment of wounds
UA71543U (en) Method for surgical treatment of oroantral fistula in deficit of tissues at distal site of defect
MY174186A (en) Use of an isopropanol-containing solution to combat caliciviridae
EA201600229A1 (en) BIS (5-AMINO-1,4-DIOXO-1,2,3,4-TETRAHYDRO-PHTHALAZIN-2-AIHs) ZINC, METHOD FOR ITS OBTAINING, PHARMACEUTICAL COMPOSITION ON ITS BASIS, MEDICAL MEANS ON ITS BASIS, SPECIAL SYSTEMS AND HEATS ARE BASED, ITEM-BASED, MEDICAL MEANS ON ITS BASIS, SPECIAL TESTS TREATMENT OF GASTRITIS
GB202012967D0 (en) Compostions and methods relating to the treatment of diseases
UA78209U (en) Method for treating patients in the second period of acute pancreatitis
UA107504C2 (en) Indriksons method for treatment of heel spur
MX2017004173A (en) Glucomannan-zno nanoparticles with healing and tissue regeneration activity.
MX368553B (en) Healing composition based on tio2 and tournefortia hirsutissima.
UA136951U (en) Method and preparation for accelerating fracture healing

Legal Events

Date Code Title Description
FG Grant or registration